Biogen Idec Inc (BIIB) 417.63 $BIIB Could This Study

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biogen Idec Inc (BIIB) 417.63 $BIIB

Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?
Sean Williams, The Motley Fool - Motley Fool - Sun Mar 08, 8:12AM CDT
Source: National Multiple Sclerosis Society, Facebook For a disease that affects 2.5 million people around the globe and more than 400,000 people in the United States, it's a shame that so little is known about multiple sclerosis despite the amount...
BIIB: 417.63 (-7.98), RCPT: 140.09 (-1.10)

2 Tiny Biotechs That Could Have Blockbuster Opportunity
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Sat Mar 07, 9:11AM CST
Smaller health care stocks are not for the faint of heart. When it comes to developing and testing new drugs, the success rate is tiny but the rewards can be huge. How can the risk-tolerant Fool spot the next Amgen or Biogen ? This health care...
JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), PTLA: 41.72 (-0.13), PFE: 33.97 (-0.50), OPHT: 53.19 (-0.29), AMGN: 154.88 (-4.72), BMY: 65.12 (-0.93), NVS: 97.46 (-1.49), CELG: 118.03 (-2.68)

Top 5 IBD 50 Drug Stocks Thriving Via Acquisitions
at Investor's Business Daily - Sat Mar 07, 7:02AM CST
The recent flurry of deal-making in the drug sector has put the spotlight on other top-rated drugmakers that have grown with the help of savvy mergers and acquisitions. In just the past week, AbbVie (ABBV) agreed to buy Pharmacyclics (PCYC) for $21...
AGN: 233.51 (-1.90), MNK: 121.33 (-0.37), JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), ACT: 289.92 (-5.78), VRX: 198.71 (-5.24), PCYC: 254.56 (+0.34), OMED: 27.55 (-0.12), AKRX: 49.83 (-1.05), SLXP: 158.01 (+0.57), ABBV: 55.64 (-1.22), CELG: 118.03 (-2.68)

ISIS Pharmaceuticals Has The Cash To Develop Its Expanding Product Pipeline
Emerging Equities - at Seeking Alpha - Fri Mar 06, 4:03PM CST

BIIB: 417.63 (-7.98), ISIS: 70.44 (-1.32), IBB: 342.36 (-5.31), GSK: 46.73 (-0.87), ETF: 12.82 (-0.18)

Stock Market News for March 06, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 9:10AM CST
Markets snapped a two-day losing streak on Thursday, somewhat boosted by the ECB announcing a trillion-dollar stimulus plan that will kick off on Monday
BIIB: 417.63 (-7.98), JNJ: 100.11 (-2.41), PCYC: 254.56 (+0.34), ADP: 86.00 (-0.75), MDT: 76.48 (-2.02), GILD: 101.81 (-1.61), ABBV: 55.64 (-1.22), BMY: 65.12 (-0.93)

Isis Pharma earns $9M milestone from Biogen
Seeking Alpha - at Seeking Alpha - Fri Mar 06, 8:28AM CST

BIIB: 417.63 (-7.98), ISIS: 70.44 (-1.32)

5 Top Medical Stocks: How To Read Their Chart Action
at Investor's Business Daily - Thu Mar 05, 5:32PM CST
Even though the market pulled back Tuesday and Wednesday, a number of medical stocks continued healthy. Biogen Idec (BIIB) scored a new high in Thursday's session. It's now more than 20% past a 347.85 buy point. In most cases, investors should take...
CNC: 62.83 (-0.42), MNK: 121.33 (-0.37), BIIB: 417.63 (-7.98), AKRX: 49.83 (-1.05), MOH: 61.27 (-1.00)

Today's Momo Momentum Stock Is Biogen Idec (BIIB)
at The Street - Thu Mar 05, 8:56AM CST
Trade-Ideas LLC identified Biogen Idec (BIIB) as a momo momentum candidate
BIIB: 417.63 (-7.98)

Market Is Looking For Positive News - Cramer's Mad Money (3/4/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Mar 05, 6:45AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, March 4. The market closed lower on Wednesday, but Cramer still thinks the market and stocks will go higher on any positive news. Citing Wayfair's (NYSE: W )...
HYH: 46.26 (+0.79), RH: 89.94 (-0.65), GPRO: 40.13 (-0.95), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PCYC: 254.56 (+0.34), KMB: 106.82 (-1.64), LLTC: 47.65 (-0.72), BMY: 65.12 (-0.93), ALKS: 68.19 (-3.03), CHRS: 27.48 (-2.23), CELG: 118.03 (-2.68), W: 28.81 (+1.03), ISIS: 70.44 (-1.32), GILD: 101.81 (-1.61), LH: 121.70 (-1.58), MCD: 97.13 (-1.98), REGN: 422.13 (-6.82), BABA: 84.40 (-1.70)

Jim Cramer's Top Takeaways: Wayfair, Honeywell, Halyard Health, More
at The Street - Thu Mar 05, 4:34AM CST
Cramer says that Honeywell is his one of his favorite industrial stocks and that the biotech sector is filled with strong buys, including Regeneron and Celgene.
HYH: 46.26 (+0.79), RH: 89.94 (-0.65), BIIB: 417.63 (-7.98), W: 28.81 (+1.03), HON: 101.87 (-1.26), GILD: 101.81 (-1.61), KMB: 106.82 (-1.64), RRD: 19.48 (+0.21), REGN: 422.13 (-6.82), CELG: 118.03 (-2.68)

Jim Cramer's 'Mad Money' Recap: The Market Is a Battlefield
at The Street - Wed Mar 04, 7:14PM CST
Investors have to pay attention to see what's really worth buying.
RH: 89.94 (-0.65), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PCYC: 254.56 (+0.34), HON: 101.87 (-1.26), KMB: 106.82 (-1.64), RRD: 19.48 (+0.21), JNJ: 100.11 (-2.41), W: 28.81 (+1.03), SCTY: 50.45 (-1.32), CMG: 658.68 (-11.81), RCPT: 140.09 (-1.10), FL: 59.37 (+2.34), REGN: 422.13 (-6.82), HYH: 46.26 (+0.79), CY: 15.10 (-0.40), SWKS: 90.75 (-0.80), VFC: 74.49 (-1.58), NXPI: 98.48 (-0.19), ALKS: 68.19 (-3.03), CELG: 118.03 (-2.68), WWAV: 41.79 (-0.63), URBN: 38.89 (+0.15), HAIN: 61.66 (-1.03), FSLR: 60.61 (-1.05), GOGO: 20.21 (+0.14), ISIS: 70.44 (-1.32), GILD: 101.81 (-1.61), MCD: 97.13 (-1.98), STM: 9.18 (-0.13), DST: 106.03 (+0.16), BIG: 48.52 (+0.70), AVGO: 127.89 (-2.68)

Top Funds Buying Rackspace, Allergan, Biogen Idec, Apple
at Investor's Business Daily - Tue Mar 03, 5:50PM CST
The nation's top-rated mutual funds the past three months have been big buyers of large medical names such as Allergan (AGN) in their latest reporting periods. IBD's biotech/biomedical group was ranked No. 1 among 197 industries as of Tuesday. Others...
AMZN: 380.09 (-7.74), BIIB: 417.63 (-7.98), MNST: 136.62 (-3.41), HD: 114.45 (-1.46), RAX: 51.14 (-0.21), PCYC: 254.56 (+0.34), SPG: 180.58 (-6.55), ORLY: 204.19 (-3.83), SLXP: 158.01 (+0.57), AGN: 233.51 (-1.90), V: 269.34 (-4.79), LNKD: 264.63 (-3.71), GOOGL: 572.90 (-8.53), LOW: 73.51 (-1.05), HBI: 32.00 (-0.14), ULTA: 138.59 (-2.27), CMCSA: 60.37 (+0.04), AAPL: 126.60 (+0.19), MA: 90.79 (-2.02)

Amgen: The Best Biotech Stock You Don't Own
Dan Strack - at Seeking Alpha - Tue Mar 03, 4:04PM CST

BIIB: 417.63 (-7.98), GILD: 101.81 (-1.61), PFE: 33.97 (-0.50), MRK: 56.84 (-1.14), AMGN: 154.88 (-4.72), ABBV: 55.64 (-1.22), GSK: 46.73 (-0.87), BMY: 65.12 (-0.93), HSP: 87.90 (+0.05), NVS: 97.46 (-1.49), CELG: 118.03 (-2.68)

Nasdaq Hits 5000: 3 Choices to Ride the Upswing - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Mar 03, 10:36AM CST
Echoes of the dot-com boom could be heard yesterday after the Nasdaq closed above 5,000 for the first time in 15 years.
AMZN: 380.09 (-7.74), BIIB: 417.63 (-7.98), FB: 80.00 (-1.21), AMGN: 154.88 (-4.72), H: 58.89 (-1.39), INTC: 33.19 (-0.54), PCLN: 1,215.99 (-15.91), CELG: 118.03 (-2.68), SBUX: 92.21 (-1.42), GILD: 101.81 (-1.61), MSFT: 42.36 (-0.75), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38), ONNN: 12.90 (-0.14)

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success, New Report Launched
M2 - Tue Mar 03, 5:18AM CST
Market Research Reports, Inc. has announced the addition of "Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success" research report to their website http://www.MarketResearchReports.com
BIIB: 417.63 (-7.98), AMGN: 154.88 (-4.72)

Big Cap 20 Reflecting Market Leadership
at Investor's Business Daily - Mon Mar 02, 5:44PM CST
The Big Cap 20 is showing itself to be a good representation of today's market leadership, as technology, health care and consumer stocks dominate the list. A glance of the IBD Smart NYSE + Nasdaq Tables shows chips, medical, apparel, retail and...
SBUX: 92.21 (-1.42), CI: 120.57 (-1.94), BIIB: 417.63 (-7.98), VRX: 198.71 (-5.24), QRVO: 72.98 (-1.53), PCYC: 254.56 (+0.34), ORLY: 204.19 (-3.83), UNH: 112.88 (-1.91), ADI: 57.93 (-0.52), MYL: 55.44 (-1.25), AAPL: 126.60 (+0.19), ROST: 104.40 (-0.55)

After Yesterday's Rally of 1.51% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 02, 3:49PM CST
Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $406.40 to a high of $416.82. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $412.02 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIIB: 417.63 (-7.98)

Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 1:10PM CST
Biogen (BIIB) and Sobi together announced positive results from a phase III study on their hemophilia B drug, Alprolix.
BIIB: 417.63 (-7.98), CBM: 33.77 (-0.63), ISIS: 70.44 (-1.32), THRX: 19.60 (-0.26)

Biogen Idec: A Great Company, But Not An Alpha Opportunity
Lee Taylor - at Seeking Alpha - Mon Mar 02, 11:39AM CST

BIIB: 417.63 (-7.98), SAN: 6.98 (-0.21), ALXN: 181.65 (-4.14), NVS: 97.46 (-1.49)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 18

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 200

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 95

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 29

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 17

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 71

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 136

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 177

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 283

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 62

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Kelly Munson Takes Charge as President and CEO of Independence Health Group

Updated Category News Views 574

Kelly Munson Appointed President and CEO Independence Health Group proudly announces that Kelly A. Munson will take the role of President and Chief Executive Officer. Beginning this new chapter, she will bring with her a wealth of experience and insight derived from her tenure with AmeriHealth Caritas, which operates under the Independence Health Group umbrella....

Continue Reading
Seek AI Achieves Dual Patents, Pioneering AI Data Workflows

Updated Category News Views 201

Innovative Patents Transforming AI Data Analytics NEW YORK-- Seek AI, the agentic AI platform designed for the modern data stack, proudly announces the acquisition of two groundbreaking patents. Awarded by the United States Patent and Trademark Office (USPTO), these patents highlight Seek AI's unique approach to human-in-the-loop workflows that utilize LLM-generated...

Continue Reading
InMed Pharmaceuticals Tackles Nasdaq Compliance Challenges

Updated Category News Views 95

InMed Pharmaceuticals Faces Nasdaq Compliance Challenge InMed Pharmaceuticals Inc. (NASDAQ: INM), a biopharmaceutical firm recognized for its innovative drug development, is actively addressing a delisting notice from Nasdaq, which is due to not meeting minimum bid price regulations. The company has formally initiated an appeal to the Nasdaq Listing Qualifications Panel...

Continue Reading
Tetragon Financial Group Investor Call Highlights and Insights

Updated Category News Views 139

Join Tetragon Financial Group for a Special Investor Call Tetragon Financial Group Limited will be hosting an important investor call to provide key updates about the company. Set for Wednesday, March 5, at 15:30 GMT / 10:30 EST, this call is a significant opportunity for investors to gain insights into Tetragon's annual report and overall company performance. What to...

Continue Reading
Exploring the Future of Bleeding Disorders Treatment Market

Updated Category News Views 214

Growing Landscape of the Bleeding Disorders Treatment Market The Bleeding Disorders Treatment Market is on a significant growth trajectory as it adapts to the rising global prevalence of conditions like hemophilia and other rare coagulation disorders. This upward trend is supported by remarkable advancements in treatment options, increasing healthcare funding, and rising...

Continue Reading